317281

Comparing The Protective Effects of L-carnitine and Erdosteine against Malathion-induced Nephrotoxicity: A Biochemical and Histopathological Experimental Study.

Article

Last updated: 04 Jan 2025

Subjects

-

Tags

-

Abstract

Malathion-induced renal impairment and the protective agents against it; are still points of research. The current study aimed at investigating and comparing between L-carnitine (LC) (100 mg/kg/day) and Erdosteine (Er) (10 mg/kg/day) regarding their protective effects against subacute nephrotoxicity of low dose Malathion (M27) (27 mg/kg/day) as well as high dose Malathion (M54) (54 mg/kg/day). Ten equal groups of adult male Sprague Dawley rats (n=6) were used as the following: Control, Corn oil, (M27), (M54), (LC), (LC+M27), (LC+M54), (Er), (Er+M27) and (Er+M54). Rats received treatments by oral gavage for 28 days. Malathion showed significant dose dependent elevation of serum creatinine, urea and renal malondialdehyde, in line with decreasing serum albumin, renal superoxide dismutase activity and renal reduced Glutathione concentration. Histologically, Malathion induced marked degenerative and inflammatory changes as well as significant dose dependent increase in Caspase-3 expression in both renal cortex and medulla compared to control. Co-administration of either LC or Er with Malathion; was associated with significant improvement of renal biochemical functions, renal oxidative stress markers, histological degenerative as well as inflammatory changes and Caspase-3 expression in both low dose and high dose Malathion groups. Moreover, LC nephroprotective effects appeared to be better than those of Er, although these differences were statistically insignificant. To conclude, it was the first time to demonstrate the nephroprotective effects of LC and Er against Malathion-induced renal dysfunction; yet the upper hand was to LC.

DOI

10.21608/mjfmct.2023.222105.1066

Keywords

malathion, L-carnitine, Erdosteine, Nephrotoxicity, Caspase-3

Authors

First Name

Heba Allah

Last Name

Abd El Rahman

MiddleName

-

Affiliation

Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine Mansoura University

Email

hebatoxo@gmail.com

City

-

Orcid

0000-0002-1566-5887

First Name

Mohamed

Last Name

Badawy

MiddleName

Moharram

Affiliation

Forensic Medicine and Clinical Toxicology Department, Faculty of Medicine, Mansoura University, Egypt

Email

dr_mmuharram85@mans.edu.eg

City

-

Orcid

-

First Name

Ahmed

Last Name

El-Sebaey

MiddleName

M

Affiliation

Department of Clinical Pathology, Faculty of Veterinary Medicine, Mansoura University, Mansoura ;Egypt

Email

dr_sebaey@mans.edu.eg

City

-

Orcid

-

First Name

Mohamed

Last Name

Hamama

MiddleName

G.

Affiliation

Anatomy Department, Faculty of Medicine, Tanta University, Tanta, Egypt

Email

mohamed.hamama@med.tanta.edu.eg

City

-

Orcid

-

First Name

Hossameldin

Last Name

Abouhish

MiddleName

-

Affiliation

Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Egypt

Email

hosadin@mans.edu.eg

City

-

Orcid

-

First Name

Shaaban

Last Name

El-Mosallamy

MiddleName

-

Affiliation

Forensic Medicine and Clinical Toxicology Department, Faculty of Medicine, Mansoura University, Egypt

Email

tigerronline@yahoo.com

City

-

Orcid

-

Volume

32

Article Issue

1

Related Issue

42030

Issue Date

2024-01-01

Receive Date

2023-07-10

Publish Date

2024-01-01

Page Start

15

Page End

37

Print ISSN

1110-5437

Online ISSN

2682-3217

Link

https://mjfmct.journals.ekb.eg/article_317281.html

Detail API

https://mjfmct.journals.ekb.eg/service?article_code=317281

Order

317,281

Type

Original Article

Type Code

966

Publication Type

Journal

Publication Title

Mansoura Journal of Forensic Medicine and Clinical Toxicology

Publication Link

https://mjfmct.journals.ekb.eg/

MainTitle

Comparing The Protective Effects of L-carnitine and Erdosteine against Malathion-induced Nephrotoxicity: A Biochemical and Histopathological Experimental Study.

Details

Type

Article

Created At

24 Dec 2024